Treatment of Secondary Progressive Multiple Sclerosis: Current Recommendations and Future Prospects

ISSN： 1173-8804

Source： BioDrugs, Vol.12, Iss.4, 1999-10, pp. : 267-277

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on Interferon- -1b in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis

By Paul L. McCormack Lesley J. Scott

BioDrugs, Vol. 18, Iss. 5, 2004-01 ,pp. : 343-347

Adis International

Access to resources Recommend Favorite

Re-Engineering Clostridial Neurotoxins for the Treatment of Chronic Pain: Current Status and Future Prospects

By Pickett Andy

BioDrugs, Vol. 24, Iss. 3, 2010-06 ,pp. : 173-182

Adis International

Access to resources Recommend Favorite

Rotavirus Vaccine: Current Status and Future Prospects

By Bernstein D.I.

BioDrugs, Vol. 14, Iss. 5, 2000-11 ,pp. : 275-281

Adis International

Access to resources Recommend Favorite

Comparative Study of Regulatory Framework for Probiotics: Current Status and Future Recommendations

Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 4, Iss. 2, 2017-08 ,pp. : 140-156

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy for Muscular Dystrophies: Current Status and Future Prospects

By Takeda S. Miyagoe-Suzuki Y.

BioDrugs, Vol. 15, Iss. 10, 2001-10 ,pp. : 635-644

Adis International

Access to resources Recommend Favorite